JP3968287B2 - 免疫分析方法 - Google Patents
免疫分析方法 Download PDFInfo
- Publication number
- JP3968287B2 JP3968287B2 JP2002277471A JP2002277471A JP3968287B2 JP 3968287 B2 JP3968287 B2 JP 3968287B2 JP 2002277471 A JP2002277471 A JP 2002277471A JP 2002277471 A JP2002277471 A JP 2002277471A JP 3968287 B2 JP3968287 B2 JP 3968287B2
- Authority
- JP
- Japan
- Prior art keywords
- value
- measured
- negative control
- substance
- negative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000003018 immunoassay Methods 0.000 title claims description 22
- 239000013642 negative control Substances 0.000 claims description 34
- 239000000126 substance Substances 0.000 claims description 26
- 229920002307 Dextran Polymers 0.000 claims description 16
- 239000003153 chemical reaction reagent Substances 0.000 claims description 14
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 239000012491 analyte Substances 0.000 claims description 4
- 238000004364 calculation method Methods 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 229960002086 dextran Drugs 0.000 description 15
- 239000000427 antigen Substances 0.000 description 12
- 102000036639 antigens Human genes 0.000 description 12
- 108091007433 antigens Proteins 0.000 description 12
- 239000004816 latex Substances 0.000 description 11
- 229920000126 latex Polymers 0.000 description 11
- 238000005259 measurement Methods 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 230000004520 agglutination Effects 0.000 description 8
- 238000004220 aggregation Methods 0.000 description 8
- 230000002776 aggregation Effects 0.000 description 8
- 241000714260 Human T-lymphotropic virus 1 Species 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000000691 measurement method Methods 0.000 description 3
- 102100023635 Alpha-fetoprotein Human genes 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 229960000633 dextran sulfate Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229920000620 organic polymer Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 101800001271 Surface protein Proteins 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 101800000385 Transmembrane protein Proteins 0.000 description 1
- 241000589886 Treponema Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- WRVRNZNDLRUXSW-UHFFFAOYSA-N acetic acid;prop-2-enoic acid Chemical compound CC(O)=O.OC(=O)C=C WRVRNZNDLRUXSW-UHFFFAOYSA-N 0.000 description 1
- XECAHXYUAAWDEL-UHFFFAOYSA-N acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- SQNNHEYXAJPPKH-UHFFFAOYSA-N chloroethene;prop-2-enoic acid Chemical compound ClC=C.OC(=O)C=C SQNNHEYXAJPPKH-UHFFFAOYSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 229940106780 human fibrinogen Drugs 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002277471A JP3968287B2 (ja) | 2002-09-24 | 2002-09-24 | 免疫分析方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002277471A JP3968287B2 (ja) | 2002-09-24 | 2002-09-24 | 免疫分析方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004117039A JP2004117039A (ja) | 2004-04-15 |
| JP2004117039A5 JP2004117039A5 (https=) | 2005-10-27 |
| JP3968287B2 true JP3968287B2 (ja) | 2007-08-29 |
Family
ID=32273061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002277471A Expired - Fee Related JP3968287B2 (ja) | 2002-09-24 | 2002-09-24 | 免疫分析方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3968287B2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103777025B (zh) * | 2012-10-18 | 2017-07-07 | 上海铭源数康生物芯片有限公司 | 蛋白质微阵列芯片的临界值一级参考品的制备方法、临界值系数的确定和实验结果判定方法 |
-
2002
- 2002-09-24 JP JP2002277471A patent/JP3968287B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004117039A (ja) | 2004-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK153589B (da) | Latex-reagens til paavisning og bestemmelse af antistoffer eller antigener, et diagnostisk middel indeholdende reagenset, en fremgangsmaade til fremstilling af dette reagens samt fremgangsmaade til paavisning eller bestemmelse af et antigen eller antistof | |
| EP0070527B1 (en) | Method of assaying biologically active substances and labelling agents therefor | |
| JPH04350559A (ja) | 特異抗体の測定法 | |
| WO2007058129A1 (ja) | 抗原の測定法およびそれに用いるキット | |
| JP2682697B2 (ja) | 免疫測定試薬および免疫測定法 | |
| Cuilliere et al. | Microparticle-enhanced nephelometric immunoassay (Nephelia) for immunoglobulins G, A, and M | |
| NO159964B (no) | Immunokjemisk reagens. | |
| JP3968287B2 (ja) | 免疫分析方法 | |
| US4792527A (en) | Method of assaying biologically active substances and labelling agents therefor | |
| JP2018173334A (ja) | 免疫学的測定方法及びそれに用いる試薬キット | |
| JP3786543B2 (ja) | 免疫学的測定試薬 | |
| JP2004117068A (ja) | 免疫測定試薬および免疫測定方法 | |
| JPS60177265A (ja) | 抗体の免疫グロブリンのクラス別検出法 | |
| WO2013118844A1 (ja) | 検出対象の検出及び定量のための方法及びキット | |
| JP4556605B2 (ja) | 標的物質の測定方法および測定試薬 | |
| JP3618797B2 (ja) | 免疫測定法 | |
| JPH0894619A (ja) | 免疫学的凝集反応試薬及びこれを用いた免疫学的定量方法 | |
| US20050130223A1 (en) | Method, system and kit for detecting an analyte in a sample | |
| JP3290520B2 (ja) | 抗リン脂質抗体測定法 | |
| JP2004117022A (ja) | 免疫測定における非特異反応抑制方法 | |
| JPH08193999A (ja) | 免疫測定法 | |
| JP4404994B2 (ja) | 免疫分析方法 | |
| JPH11258236A (ja) | 抗リン脂質抗体測定試薬 | |
| JP2002181822A (ja) | 免疫測定試薬及び免疫測定法 | |
| JPH11337550A (ja) | 免疫測定試薬および免疫測定法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050726 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050726 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20070425 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070511 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070604 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100608 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130608 Year of fee payment: 6 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |